2010Accuracy of Methods for Urinary Detection in Women with Stress Urinary Incontinence. 대한비뇨기과학회지 2010;51:537
2010Relationship between Prostate-Specific Antigen and Body Mass Index according to Age: Lower Prostate-Specific Antigen in Middle-Aged Overweight and Obese Korean Men. Urologia Int 2010;85:143
2009Clinical Implication of Serum C-Reactive Protein in Patients With Uncomplicated Acute Pyelonephritis as Marker of Prolonged Hospitalization and Recurrence. Urology 2009;73:19
2009전립선비대증 환자에서 교육 후 전립선비대증에 대한 치료 관점의 변화. 대한비뇨기과학회지 2009;50:340
2009기저 전립선특이항원치 및 나이에 따른 전립선특이항원의 측정주기. 대한비뇨기과학회지2009;50:1059
2009방광암에서 근치적 혹은 부분 방광절제술 후 절제면 양성. 대한비뇨기종양학회지 2009;7:122
2008전립선특이항원 절단치가 전립선 생검 환자 수에 미치는 영향. 대한비뇨기과학회지 2008;49:118
2008방광종양의 생물학적 표지인지인 Ki-67, Apoptotic Index 및 CD34의 예후적 가치: 분화도, 병기, 진행 및 재발과의 관계. 대한비뇨기종양학회지 2008;6:124
2008A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma. YMJ 2008;49:451
2008Prostate-specific antigen velocity in healthy Korean men with initial PSA levels of 4.0 ng/mL or less. Urology 2008;72:99
2008전립선과 비만. Prostate Update 2008;11:99
2008A multi-institutional study on histopathological characteristics of surgically treated renal tumors: the importance of tumor size. Yonsei Medical Journal 2008;49:639
2006Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: A multicenter study. Urology 2006;67:333
2006Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study. BJU Int 2006;97:742
2005Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma. YMJ 2005;46:835
2004Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 2004;23:1333
2002Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Can Res 2002;62:3649
2002Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis in Androgen-independent Human Prostate Cancer Cell Lines. Can Res 2002;62:5365
2002Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer Cells. J Biol Chem 2002;277:32510